capital
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
July 15, 2026
OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup with a $2 billion valuation, and Lightspeed is reportedly discussing leading the funding round. The deal signals continued investor appetite for AI-powered biotech startups, especially those attracting backing from top-tier firms like Lightspeed.
Lightspeed is in discussions to lead the funding round, sources say.
Source: techcrunch.com